S. McInerny

发表

Breast cancer polygenic risk scores: a 12-month prospective study of patient reported outcomes and risk management behavior.

B. Meiser, T. Yanes, R. Kaur, 2021, Genetics in medicine : official journal of the American College of Medical Genetics.

Communicating polygenic risk scores in the familial breast cancer clinic.

B. Meiser, T. Yanes, R. Kaur, 2021, Patient education and counseling.

Women’s responses and understanding of polygenic breast cancer risk information

B. Meiser, T. Yanes, R. Kaur, 2019, Familial Cancer.

Integration of tumour sequencing and case–control data to assess pathogenicity of RAD51C missense variants in familial breast cancer

R. Scott, N. Li, E. Thompson, 2021, npj Breast Cancer.

Panel Testing for Familial Breast Cancer: Calibrating the Tension Between Research and Clinical Care.

R. Scott, E. Thompson, I. Campbell, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prevalence of PALB2 mutations in Australian familial breast cancer cases and controls

Kylie L. Gorringe, R. Scott, M. Doyle, 2015, Breast Cancer Research.

Combined tumor sequencing and case/control analyses of RAD51C in breast cancer.

Kylie L. Gorringe, S. Fox, I. Campbell, 2019, Journal of the National Cancer Institute.

Integration of tumour sequencing and case–control data to assess pathogenicity of RAD51C missense variants in familial breast cancer

R. Scott, E. Thompson, I. Campbell, 2022, NPJ breast cancer.

Evaluation of the association of heterozygous germline variants in NTHL1 with breast cancer predisposition: an international multi-center study of 47,180 subjects

Kylie L. Gorringe, E. Ziv, J. Hopper, 2021, npj Breast Cancer.

Molecular analysis of PALB2‐associated breast cancers

Kylie L. Gorringe, I. Campbell, S. McInerny, 2018, The Journal of pathology.

Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes

I. Campbell, S. McInerny, P. James, 2020, Nature Communications.

Reevaluation of the BRCA2 truncating allele c.9976A > T (p.Lys3326Ter) in a familial breast cancer context

Kylie L. Gorringe, A. Kavanagh, S. Fox, 2015, Scientific Reports.

Evaluating the breast cancer predisposition role of rare variants in genes associated with low-penetrance breast cancer risk SNPs

E. Thompson, I. Campbell, S. McInerny, 2018, Breast Cancer Research.

Evaluation of the association of heterozygous germline variants in NTHL1 with breast cancer predisposition: an international multi-center study of 47,180 subjects

Kylie L. Gorringe, E. Ziv, J. Hopper, 2021, NPJ breast cancer.

Mutations in RECQL are not associated with breast cancer risk in an Australian population

E. Thompson, I. Campbell, S. McInerny, 2018, Nature Genetics.

Somatic inactivation of breast cancer predisposition genes in tumors associated with pathogenic germline variants

R. Scott, I. Campbell, S. McInerny, 2022, Journal of the National Cancer Institute.

Polygenic risk in familial breast cancer: Changing the dynamics of communicating genetic risk

B. Meiser, T. Yanes, R. Kaur, 2021, Journal of genetic counseling.

Development and evaluation of a novel educational program for providers on the use of polygenic risk scores

T. Yanes, M. Young, S. McInerny, 2023, medRxiv.

Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes

David G. Morris, Kylie L. Gorringe, M. Pike, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Uptake of polygenic risk information among women at increased risk of breast cancer

B. Meiser, T. Yanes, R. Kaur, 2019, Clinical genetics.

Investigation of monogenic causes of familial breast cancer: data from the BEACCON case-control study

Kylie L. Gorringe, R. Scott, E. Thompson, 2021, NPJ breast cancer.

Contribution of large genomic rearrangements in PALB2 to familial breast cancer: implications for genetic testing

R. Scott, I. Campbell, S. McInerny, 2022, Journal of Medical Genetics.

Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes

Kylie L. Gorringe, I. Campbell, S. McInerny, 2020, Nature Communications.

Reevaluation of RINT1 as a breast cancer predisposition gene

Kylie L. Gorringe, R. Scott, E. Thompson, 2016, Breast Cancer Research and Treatment.

Women’s responses and understanding of polygenic breast cancer risk information

B. Meiser, T. Yanes, R. Kaur, 2020, Familial Cancer.

Breast cancer polygenic risk scores: a 12-month prospective study of patient reported outcomes and risk management behavior

B. Meiser, T. Yanes, R. Kaur, 2021, Genetics in Medicine.

Mutations in RECQL are not associated with breast cancer risk in an Australian population

Kylie L. Gorringe, R. Scott, E. Thompson, 2018, Nature Genetics.

ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk

James M. Hodge, E. Burnside, Y. Kamatani, 2023, Clinical cancer research : an official journal of the American Association for Cancer Research.

Evaluating the breast cancer predisposition role of rare variants in genes associated with low-penetrance breast cancer risk SNPs

Kylie L. Gorringe, E. Thompson, I. Campbell, 2018, Breast Cancer Research.

Panel Testing for Familial Breast Cancer: Calibrating the Tension Between Research and Clinical Care.

E. Thompson, I. Campbell, S. McInerny, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.